With significant therapeutic advances in the field of pulmonary arterial hypertension, the
need to identify clinically relevant treatment goals that correlate with long-term outcome has …

Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed
in adulthood. Although considered a simple defect, challenges in optimal diagnostic and …

Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A
Report of the American College of Cardiology/American Heart Association Task Force on …

The recommendations listed in this guideline are, whenever possible, evidence-based. An
initial extensive evidence review, which included literature derived from research involving …

Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Pulmonary arterial hypertension (PAH) is a progressive, fatal disease. We studied 674
consecutive adult patients who were prospectively enrolled in the French PAH registry (121 …

Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists
reflecting the spectrum of disease across the five diagnostic groups encountered in a …

Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …